Âé¶¹´«Ã½Ó³»­

Âé¶¹´«Ã½Ó³»­

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Attitudes and Preferences on Mental Health and Care Delivery Among Patients with Multiple Sclerosis: Racial and Ethnic Considerations
Practice, Policy, and Ethics
P8 - Poster Session 8 (8:00 AM-9:00 AM)
7-003

We aimed to evaluate attitudes and preferences on mental health (MH) and MH care (MHC) delivery in persons with multiple sclerosis (MS) across racial/ethnic groups.

Despite being at increased risk of psychiatric comorbidity, MH disorders in individuals living with MS, particularly racial/ethnic minorities, are underdiagnosed and undertreated.

We surveyed persons with self-reported MS on their attitudes about MH and MHC preferences. We also administered patient-reported measures including the Patient Health Questionnaire-9. MS organizations distributed survey invitations electronically. Analyses were conducted using comparison of proportions.

2246 persons (2100 Caucasian [CA], 143 African-American [AA]; 125 Hispanic [H]; age 51.2±12.3, 69.8% moderate-to-severe depression) completed the survey. Participants of all racial/ethnic groups reported that emotional problems are common with MS (83.4%) and could worsen MS symptoms (83.3%). A total of 26.6% have an MH provider (MHP) and 29.8% previously had one, the top reasons for stopping treatment included: “got better” (47.8%), “wanted to handle problems on own” (8.7%), “too expensive” (8.3%), “lack of time/transportation” (5.8%), and “bad experiences with treatment” (4.3%). 74.4% of respondents would attend MHC visits if co-located with their MS care, while higher proportions of H (88.6%) compared to non-Hispanics (NH) (73.8%) (p=<0.001) and AA (82.1%) compared to CA (73.8%) would attend if co-located (p=0.003). AA reported stronger preferences to be matched with an MHP of the same race/ethnicity (25.2% AA, 11.2% CA, p=<0.001), gender (37.8% AA, 28.3% CA, p=0.001), age group (26.1% AA, 20.8% CA, p=<0.001), and religion (21.8% AA, 14.0% CA, p=0.01). Compared to CA, AA would feel better understood (28.0% AA, 11.2% CA, p=<0.001) and would trust more (18.4% AA, 7.5% CA, p=<0.001) if their MHP shared their race/ethnicity.

MS affects a diverse population with varying attitudes/preferences on MH in MS and MHC delivery. Understanding these differences may facilitate the development of a patient-centered approach.

Authors/Disclosures
Daniela A. Pimentel Maldonado, MD, MSCR (U.S. Food and Drug Administration)
PRESENTER
Dr. Pimentel Maldonado has nothing to disclose.
Carolina Ionete, MD (UMass Memorial) Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Sanofi. Dr. Ionete has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Zenas. Dr. Ionete has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Sanofi. The institution of Dr. Ionete has received research support from Genetech. The institution of Dr. Ionete has received research support from NIH.
Christopher Hemond, MD (University of Massachusetts Memorial Medical Center) The institution of Dr. Hemond has received research support from Consorium of Multiple Sclerosis Centers. The institution of Dr. Hemond has received research support from National Institute Of Neurological Disorders And Stroke of the National Institutes of Health. Dr. Hemond has received personal compensation in the range of $0-$499 for serving as a Member of Data Safety and Monitoring Board with National Institute Of Neurological Disorders And Stroke of the National Institutes of Health.
Idanis Berrios Morales, MD (University of Massachusetts Medical School) Dr. Berrios Morales has nothing to disclose.
Raffaella Umeton, MD, PhD, MMSc Dr. Umeton has nothing to disclose.
No disclosure on file